Yorkville Advisors Global, LP
Position in JUNS — Jupiter Neurosciences, Inc.
CIK 1838613
Mountainside, NJ
Position in JUNS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$48,504
-$86,043 QoQ
Shares Held
129,000
-2.2% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 10 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JUNS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Yorkville Advisors Global, LP holds $107,394 across 2 Biotechnology names. JUNS ranks #2 (45.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NRSN |
NeuroSense Therapeutics Ltd.
|
78,000 | $58,890 | |
| 2 | JUNS |
Jupiter Neurosciences, Inc.
This page
|
129,000 | $48,504 |
All Filings in JUNS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,504 | 129,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $134,547 | 131,909 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||